Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

SES: Statement of transactions in own shares from May 24, 2021 to May 28, 2021
SES: Statement of transactions in own shares from May 24, 2021 to May 28, 2021


 

Statement of transactions in own shares from May 24, 2021 to May 28, 2021
EXANE BNP PARIBAS

 

Aggregated presentation by day and by market

 

Name of

Interactive Brokers Group to Present at Piper Sandler Global Exchange & FinTech Conference
Interactive Brokers Group to Present at Piper Sandler Global Exchange & FinTech Conference


Interactive Brokers Group, Inc. (Nasdaq: IBKR) announces that its Chairman Thomas Peterffy will speak at the Piper Sandler Global Exchange & FinTech Conference on Wednesday, June 9th at 8:00 a.m

NICE Actimize Announces ENGAGE LIVE, the Industry’s Largest Virtual Financial Crime Event Featuring Three Keynotes by Renowned Global Talent
NICE Actimize Announces ENGAGE LIVE, the Industry’s Largest Virtual Financial Crime Event Featuring Three Keynotes by Renowned Global Talent


NICE Actimize, a business of NICE (Nasdaq: NICE) today launched ENGAGE LIVE, the financial crime industry’s largest virtual customer event of the year. Featuring an agenda packed with

Helmerich & Payne, Inc. To Participate in Virtual Conferences in June 2021
Helmerich & Payne, Inc. To Participate in Virtual Conferences in June 2021


Helmerich & Payne, Inc. (NYSE: HP) today announced that John Lindsay, President and Chief Executive Officer; Mark Smith, Senior Vice President and Chief Financial Officer; Dave Wilson, Vice

Royal Gold Presenting at the 44th Nasdaq Virtual Investor Conference
Royal Gold Presenting at the 44th Nasdaq Virtual Investor Conference


Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that management will present at the 44th Nasdaq Virtual Investor

Interactive Brokers Group Reports Brokerage Metrics and Other Financial Information for May 2021, Includes Reg.-NMS Execution Statistics
Interactive Brokers Group Reports Brokerage Metrics and Other Financial Information for May 2021, Includes Reg.-NMS Execution Statistics


Interactive Brokers Group, Inc. (Nasdaq: IBKR) an automated global electronic broker, today reported its Electronic Brokerage monthly performance metrics for May.



Brokerage highlights for the

Semtech Advances Commitment to Corporate Citizenship
Semtech Advances Commitment to Corporate Citizenship


Semtech Corporation (Nasdaq: SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, announced it has advanced its efforts on key

LivaNova Completes Initial Closing of Heart Valve Business to Gyrus Capital
LivaNova Completes Initial Closing of Heart Valve Business to Gyrus Capital


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has successfully completed the initial closing of the divestiture of its heart valve (HV)

Bibel TV Extends Capacity Agreement with SES on ASTRA 19.2 degrees East
Bibel TV Extends Capacity Agreement with SES on ASTRA 19.2 degrees East


The Bibel TV Foundation, Germany’s leading Christian-oriented free-TV station, has extended its partnership with SES in a new multi-year contract that secures additional capacity for the Foundation

Gap Inc. Reports First Quarter Results
Gap Inc. Reports First Quarter Results


Gap Inc. (NYSE: GPS), a portfolio of purpose-led, lifestyle brands including Old Navy, Gap, Banana Republic, and Athleta, and the largest specialty apparel company in the U.S., reported first

Xencor to Present at the Jefferies Virtual Healthcare Conference
Xencor to Present at the Jefferies Virtual Healthcare Conference


Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today

Eurofins Awarded U.S. Government Agreement to Expand National Covid-19 Testing
Eurofins Awarded U.S. Government Agreement to Expand National Covid-19 Testing


Clinical Enterprise, Inc., a Eurofins Scientific company, today announced it has been awarded a U.S. Government agreement to expand national COVID-19 testing. The agreement with the U.S. Department

Roku Inks First Ever Pay-One Window Rights Deal With Saban Films
Roku Inks First Ever Pay-One Window Rights Deal With Saban Films


Roku, Inc. (NASDAQ:ROKU) and Saban Films today announced a landmark agreement granting Roku® the pay-one window streaming rights to movies released by Saban Films. Under the agreement, a selection

PulteGroup’s Built to Honor Program Awards Mortgage-Free Home to United States Marine Corps Veteran in Dallas
PulteGroup’s Built to Honor Program Awards Mortgage-Free Home to United States Marine Corps Veteran in Dallas


In a special dedication event, United States Marine Corps Sergeant Patrick Murray received the keys to his new mortgage-free Pulte Home in the Somerset community in Mansfield, Texas. The home was

Gap and Walmart Partner to Introduce Gap Home The First-Ever Home Collection from Gap, the Leading Casual Lifestyle Brand
Gap and Walmart Partner to Introduce Gap Home The First-Ever Home Collection from Gap, the Leading Casual Lifestyle Brand


Gap and Walmart today announced a strategic partnership to introduce Gap Home, a new brand of home essentials available exclusively at Walmart. With this launch, two of the world’s most iconic

Sotrovimab (VIR-7831), an Investigational Antibody Utilizing Xencor's Xtend™ Technology, Receives U.S. FDA Emergency Use Authorization for the Treatment of COVID-19
Sotrovimab (VIR-7831), an Investigational Antibody Utilizing Xencor's Xtend™ Technology, Receives U.S. FDA Emergency Use Authorization for the Treatment of COVID-19


Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today

Acadia Healthcare to Participate in the Jefferies Virtual Healthcare Conference
Acadia Healthcare to Participate in the Jefferies Virtual Healthcare Conference


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Jefferies Virtual Healthcare Conference, which takes place June 1 – June 4, 2021. There will

NICE Recognizes Trailblazers in Creating Next-Gen CX, Unveiling CX Excellence Award Winners at Interactions Live 2021
NICE Recognizes Trailblazers in Creating Next-Gen CX, Unveiling CX Excellence Award Winners at Interactions Live 2021


NICE (Nasdaq: NICE) today announced the winners of its CX Excellence Awards 2021. The winning organizations were recognized for driving creative, innovative customer interactions resulting in

Diodes Incorporated to Participate at Upcoming Financial Conferences
Diodes Incorporated to Participate at Upcoming Financial Conferences


Diodes Incorporated (Nasdaq: DIOD), today announced that management will participate at the following virtual financial conferences.



Cowen 2021 Technology, Media and Telecom Conference
Date

Royal Gold Announces Third Quarter Dividend
Royal Gold Announces Third Quarter Dividend


Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that its Board of Directors has declared its third quarter dividend of

Cirrus Logic to Present at Upcoming Conferences
Cirrus Logic to Present at Upcoming Conferences


Cirrus Logic, Inc. (Nasdaq: CRUS) today announced that the company will be presenting at the following investor conferences:




  • June 2 – Cirrus Logic President and Chief Executive Officer John

LiveRamp Announces Fourth Quarter and Fiscal Year Results
LiveRamp Announces Fourth Quarter and Fiscal Year Results


LiveRamp® (NYSE: RAMP), the leading global data connectivity platform, today announced its financial results for the quarter and fiscal year ended March 31, 2021.


This press release features

Xencor and Bristol Myers Squibb Enter License Agreement for Use of Xtend™ XmAb® Technology in SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19
Xencor and Bristol Myers Squibb Enter License Agreement for Use of Xtend™ XmAb® Technology in SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced

Novocure Announces Clinical Trial Collaboration with GT Medical Technologies to Evaluate Tumor Treating Fields Together with GammaTile® Therapy in Recurrent Glioblastoma
Novocure Announces Clinical Trial Collaboration with GT Medical Technologies to Evaluate Tumor Treating Fields Together with GammaTile® Therapy in Recurrent Glioblastoma


Novocure (NASDAQ: NVCR) today announced it has entered into a clinical trial collaboration agreement with GT Medical Technologies, Inc., to develop Tumor Treating Fields (TTFields) together with GT

Large Latin American Financial Institution Moves 10,000 Agents to NICE CXone
Large Latin American Financial Institution Moves 10,000 Agents to NICE CXone


NICE CXone (Nasdaq: NICE) today announced one of the largest financial institutions in Latin America has chosen CXone, the industry’s most proven, complete and smart customer experience platform